Declining Morning Salivary Cortisol: Interpretation and Management
Your patient's morning salivary cortisol has declined from 2.7 µg/dL to 1.4 µg/dL, which indicates persistent adrenal insufficiency requiring continued physiologic glucocorticoid replacement and repeat testing in several months.
Understanding the Values
Both salivary cortisol measurements fall well below the threshold that would indicate HPA axis recovery. While the guidelines primarily reference serum cortisol values, the interpretation framework applies similarly to salivary measurements:
- Serum cortisol <5 µg/dL (150 nmol/L) indicates very likely persistent adrenal insufficiency 1
- Serum cortisol >10 µg/dL (300 nmol/L) indicates HPA axis recovery 1
- Salivary cortisol reflects free (bioavailable) cortisol and typically runs lower than total serum cortisol 2
Your patient's values of 2.7 and 1.4 µg/dL are both in the range suggesting persistent adrenal insufficiency, with the declining trend being particularly concerning as it suggests worsening rather than recovery of HPA axis function.
Clinical Significance of the Decline
The drop from 2.7 to 1.4 µg/dL represents approximately a 48% decrease. This trajectory is moving in the wrong direction for HPA axis recovery. According to the 2024 ESE/ES guidelines, patients with very low morning cortisol levels (<5 µg/dL serum equivalent) are very likely to have persistent adrenal insufficiency, and dynamic testing is unlikely to be useful 1.
Immediate Management Recommendations
Continue physiologic glucocorticoid replacement (e.g., hydrocortisone 15-25 mg daily or prednisone 4-6 mg daily) 1. The dose should:
- Provide sufficient replacement to prevent adrenal crisis
- Avoid over-replacement that could further suppress the HPA axis
- Allow for potential recovery stimulus 1
Monitoring Strategy
Repeat morning cortisol testing in 3-6 months 1. The frequency depends on:
- Duration and dose of prior glucocorticoid therapy
- Current replacement dose
- Trajectory of previous cortisol values (yours is declining, suggesting longer interval may be appropriate)
Given the declining trend, consider the longer end of this interval (4-6 months) to allow adequate time for potential recovery 1.
Critical Safety Considerations
Stress Dose Coverage
This patient requires stress dose coverage for any significant physiologic stress 1. Specifically:
- Minor illness: Double the usual glucocorticoid dose 3
- Severe illness, vomiting, diarrhea: Emergency department evaluation for IV hydrocortisone 100 mg followed by 200 mg continuous infusion 3
- Minor surgery: 25-75 mg IV hydrocortisone 3
- Major surgery: 100 mg IV hydrocortisone followed by 200 mg continuous infusion over 24 hours 3
Patient Education Requirements
The patient should:
- Carry an emergency card indicating adrenal insufficiency management 3
- Have a hydrocortisone emergency injection kit 3
- Understand "sick day rules" for dose adjustment 3
When to Consider Specialist Referral
Refer to endocrinology if 1:
- No HPA axis recovery after one year on physiologic replacement
- History of adrenal crisis
- Uncertainty about management or diagnosis
Factors That Could Affect Interpretation
Before attributing these values solely to adrenal insufficiency, consider 1:
- Circadian rhythm disruption: Night shift work, jet lag, severe insomnia can falsely lower morning cortisol
- Low albumin states: Cirrhosis, nephrotic syndrome, malnutrition (though salivary cortisol is less affected than serum)
- Assay variability: Different methods yield different results; ensure consistent testing methodology 1
- Collection timing: Salivary cortisol should be collected immediately upon waking for morning values
What NOT to Do
- Do not perform dynamic testing (e.g., ACTH stimulation test) at these low cortisol levels—it's unlikely to add useful information 1
- Do not discontinue glucocorticoids with values this low
- Do not use fludrocortisone unless there's documented mineralocorticoid deficiency (not typical in secondary/glucocorticoid-induced AI) 1
Context Matters
The clinical context is essential. If this patient has:
- Recent/current glucocorticoid therapy: This represents glucocorticoid-induced adrenal insufficiency requiring continued replacement 1
- Pituitary disease: This represents secondary adrenal insufficiency requiring long-term replacement
- No clear cause: Further evaluation for underlying etiology is warranted
The declining trend from 2.7 to 1.4 µg/dL suggests the HPA axis is not recovering and may even be worsening, necessitating vigilant management and patient education about adrenal crisis prevention.